Ambio Life Sciences operates medical-grade ibogaine treatment facilities in Baja California, Mexico and Malta. The organization has conducted over 3,000 treatments and developed safety protocols adopted globally. Ambio’s research collaboration with Stanford University on ibogaine for traumatic brain injury and PTSD in veterans was published in Nature Medicine. Programs include addiction cessation, neurological condition treatment (Parkinson’s, MS, stroke, ALS), and personal optimization, with 24/7 physician and therapist staffing.
Legal status varies by jurisdiction and changes over time. Verify current local law before any decision. Source citation appears with each legal claim.
Source: Mexican Federal Law of Health (Ley General de Salud), Article 245 controlled substances list. Pending editorial verification of specific article references. — last reviewed April 26, 2026